Your browser is no longer supported. Please, upgrade your browser.
NNVC [AMEX]
NanoViricides, Inc.
Index- P/E- EPS (ttm)-0.82 Insider Own5.17% Shs Outstand11.52M Perf Week-22.03%
Market Cap29.39M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.93M Perf Month-43.77%
Income-9.10M PEG- EPS next Q-0.22 Inst Own8.30% Short Float2.36% Perf Quarter-54.81%
Sales- P/S- EPS this Y66.20% Inst Trans-0.09% Short Ratio1.57 Perf Half Y-45.75%
Book/sh2.46 P/B0.93 EPS next Y- ROA-30.30% Target Price8.75 Perf Year-48.08%
Cash/sh1.54 P/C1.49 EPS next 5Y- ROE-31.00% 52W Range2.55 - 8.71 Perf YTD-38.17%
Dividend- P/FCF- EPS past 5Y26.30% ROI- 52W High-73.59% Beta0.78
Dividend %- Quick Ratio22.90 Sales past 5Y- Gross Margin- 52W Low-9.80% ATR0.25
Employees17 Current Ratio22.90 Sales Q/Q- Oper. Margin- RSI (14)22.54 Volatility8.68% 8.35%
OptionableYes Debt/Eq0.00 EPS Q/Q-3.00% Profit Margin- Rel Volume0.85 Prev Close2.55
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume164.69K Price2.30
Recom2.00 SMA20-30.72% SMA50-42.83% SMA200-44.81% Volume140,042 Change-9.80%
Feb-11-15Initiated Midtown Partners Strong Buy $5.30
Nov-16-21 06:45AM  
Nov-15-21 07:31AM  
06:45AM  
06:18AM  
Oct-13-21 06:45AM  
Oct-11-21 08:25AM  
06:45AM  
Oct-05-21 08:31AM  
06:45AM  
Sep-28-21 09:28AM  
Sep-27-21 07:02AM  
06:45AM  
Sep-22-21 06:45AM  
06:45AM  
Sep-21-21 02:18PM  
Sep-14-21 12:04PM  
07:32AM  
06:45AM  
Jun-28-21 08:28AM  
Jun-22-21 12:49PM  
May-17-21 06:45AM  
Mar-09-21 08:08AM  
05:45AM  
Mar-02-21 08:01AM  
06:15AM  
04:43AM  
Feb-18-21 04:59AM  
Feb-17-21 06:15AM  
Feb-08-21 07:40AM  
06:15AM  
Jan-27-21 06:15AM  
Nov-19-20 06:20AM  
Nov-18-20 11:49AM  
Nov-17-20 06:20AM  
Nov-11-20 10:55AM  
06:20AM  
Oct-15-20 06:15AM  
Sep-18-20 05:35PM  
Sep-16-20 06:15AM  
Sep-08-20 09:10AM  
Sep-04-20 06:50AM  
Sep-02-20 06:15AM  
Aug-31-20 05:00PM  
08:40AM  
Aug-06-20 01:43PM  
Jul-23-20 11:48AM  
Jul-21-20 06:15AM  
Jul-20-20 06:10PM  
Jul-16-20 03:16PM  
10:52AM  
Jul-13-20 06:30AM  
Jul-09-20 06:15AM  
Jul-08-20 05:55PM  
05:50PM  
06:15AM  
Jun-30-20 06:15AM  
Jun-25-20 11:05AM  
Jun-23-20 06:15AM  
Jun-09-20 07:46AM  
06:15AM  
May-26-20 06:15AM  
May-21-20 08:30AM  
May-20-20 06:15AM  
May-18-20 06:15AM  
May-13-20 10:12AM  
May-12-20 12:57PM  
06:15AM  
May-04-20 06:15AM  
Apr-29-20 06:15AM  
Apr-21-20 02:00PM  
Apr-13-20 06:15AM  
Apr-07-20 02:31PM  
11:49AM  
Apr-06-20 06:15AM  
Mar-31-20 07:30AM  
Mar-16-20 06:15AM  
Mar-14-20 10:18AM  
Mar-13-20 05:42PM  
Mar-09-20 02:44PM  
Mar-05-20 04:11PM  
Feb-28-20 04:57PM  
Feb-25-20 03:25PM  
Feb-24-20 08:39AM  
08:04AM  
06:15AM  
Feb-18-20 01:01PM  
Feb-12-20 06:15AM  
Feb-10-20 07:30AM  
Feb-06-20 05:50PM  
Feb-04-20 07:30AM  
Feb-03-20 02:17PM  
08:59AM  
Feb-01-20 10:53AM  
Jan-31-20 09:09AM  
Jan-30-20 06:20PM  
10:54AM  
Jan-28-20 02:23PM  
07:53AM  
Jan-27-20 04:29PM  
04:03PM  
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.